Comparison of Outcomes From Intermittent Hemodialysis and Continuous Renal Replacement Therapy With Systemic or Regional Anticoagulation in 128 Patients in a Polish Intensive Care Unit

27 January 2026 : Database Analysis

Joanna Wolska

^{ABCDEF 1,2*}, Dariusz Onichimowski

^{ACD 1,2}, Milena Samiec

^{E 1,3}, Iwona Podlińska

^{E 1,3}, Paweł Radkowski^{E 1,3}

DOI: 10.12659/MSM.949686

Med Sci Monit 2026; 32:e949686

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 ICU mortality, in-hospital deaths, and 90-day mortality for particular cohorts: IHD, HEP and CITR.

Variable	IHD		HEP		CITR		Test result	P value
Variable	N	%	N	%	N	%	Test result	P value
Death in ICU
No	12	29.27%	14	35.00%	13	27.66%	0.591	0.744
Yes	29	70.73%	26	65.00%	34	72.34%	0.591	0.744
In-hospital death
No	9	21.95%	11	27.50%	10	21.28%	0.541	0.763
Yes	32	78.05%	29	72.50%	37	78.72%	0.541	0.763
Death within 90 days
No	9	21.95%	11	27.50%	11	23.40%	0.367	0.833
Yes	32	78.05%	29	72.50%	36	76.60%	0.367	0.833
Pearson chi-square test. CITR – patients subject to continuous renal replacement therapy with citrate anticoagulation; HEP – patients receiving continuous renal replacement therapy with heparin anticoagulation; IHD – patients receiving intermittent hemodialysis.

Back to the Article